![Pam Stetkiewicz](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Pam Stetkiewicz
Direttore operativo presso Arbor Biotechnologies, Inc.
Posizioni attive di Pam Stetkiewicz
Società | Posizione | Inizio | Fine |
---|---|---|---|
Arbor Biotechnologies, Inc.
![]() Arbor Biotechnologies, Inc. BiotechnologyHealth Technology Arbor Biotechnologies, Inc. engages in curating genetic biodiversity and discover novel protein functions from nature. The company was founded by David Arthur Svott, Winston Xia Yan, Feng Zhang and David R. Walt in 2016 and is headquartered in Cambridge, MA. | Direttore operativo | 20/07/2021 | - |
ImmuneID, Inc.
![]() ImmuneID, Inc. Miscellaneous Commercial ServicesCommercial Services ImmuneID, Inc. is a precision immunology company that combines next-generation sequencing with protein display technologies to develop novel therapies for immune diseases. The company's proprietary platform identifies millions of antibody-target interactions to build the map of human immunity, which helps to improve and personalize patient diagnoses for precise treatments. The company was founded in 2020 by Longwood Fund and is headquartered in Boston, MA. James S. Scibetta has been the CEO of the company since 2021. | Direttore/Membro del Consiglio | 12/07/2022 | - |
Storia della carriera di Pam Stetkiewicz
Formazione di Pam Stetkiewicz
The Johns Hopkins University | Doctorate Degree |
University of Rhode Island | Undergraduate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 5 |
Posizioni
Chief Operating Officer | 1 |
Doctorate Degree | 1 |
Undergraduate Degree | 1 |
Settori
Consumer Services | 3 |
Health Technology | 2 |
Commercial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 2 |
---|---|
Arbor Biotechnologies, Inc.
![]() Arbor Biotechnologies, Inc. BiotechnologyHealth Technology Arbor Biotechnologies, Inc. engages in curating genetic biodiversity and discover novel protein functions from nature. The company was founded by David Arthur Svott, Winston Xia Yan, Feng Zhang and David R. Walt in 2016 and is headquartered in Cambridge, MA. | Health Technology |
ImmuneID, Inc.
![]() ImmuneID, Inc. Miscellaneous Commercial ServicesCommercial Services ImmuneID, Inc. is a precision immunology company that combines next-generation sequencing with protein display technologies to develop novel therapies for immune diseases. The company's proprietary platform identifies millions of antibody-target interactions to build the map of human immunity, which helps to improve and personalize patient diagnoses for precise treatments. The company was founded in 2020 by Longwood Fund and is headquartered in Boston, MA. James S. Scibetta has been the CEO of the company since 2021. | Commercial Services |
- Borsa valori
- Insiders
- Pam Stetkiewicz
- Esperienza